Literature DB >> 7833589

The role of interleukin-6 in certain age-related diseases.

W B Ershler1, W H Sun, N Binkley.   

Abstract

Interleukin-6 (IL-6) is a pro-inflammatory cytokine with a wide range of functions. Perhaps the most important physiologically is its role as a mediator of the acute phase inflammatory response. Normally, there is little measurable IL-6 in the circulation, but levels increase abruptly to nanogram amounts during an inflammatory process. During aging, it has been proposed that the tight regulation of IL-6 gene expression becomes less effective and levels are measurable even when there is no evidence for inflammation. Several investigators have identified this cytokine as being involved in the pathogenesis of various disease processes and we have suggested that certain age-associated diseases are directly related. Among these are late-life lymphoma and myeloma, osteoporosis and possibly Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7833589     DOI: 10.2165/00002512-199405050-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  58 in total

1.  Inhibiting IL-6 in human multiple myeloma.

Authors:  B Klein; Z Y Lu; J P Gaillard; J L Harousseau; R Bataille
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

Review 2.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

3.  Interleukin-6: an osteotropic factor?

Authors:  G D Roodman
Journal:  J Bone Miner Res       Date:  1992-05       Impact factor: 6.741

4.  Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma.

Authors:  X G Zhang; B Klein; R Bataille
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

5.  Constitutive production of interleukin-6 and immunologic features in cardiac myxomas.

Authors:  M Jourdan; R Bataille; J Seguin; X G Zhang; P A Chaptal; B Klein
Journal:  Arthritis Rheum       Date:  1990-03

6.  Radioimmunoassay for the measurement of serum IL-6 and its correlation with tumour cell mass parameters in multiple myeloma.

Authors:  E Solary; M Guiguet; V Zeller; R O Casasnovas; D Caillot; P Chavanet; H Guy; G Mack
Journal:  Am J Hematol       Date:  1992-03       Impact factor: 10.047

7.  Increased production of TGF-beta and Il-6 by aged spleen cells.

Authors:  D Zhou; F J Chrest; W Adler; A Munster; R A Winchurch
Journal:  Immunol Lett       Date:  1993-04       Impact factor: 3.685

8.  Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA.

Authors:  E M Greenfield; S A Gornik; M C Horowitz; H J Donahue; S M Shaw
Journal:  J Bone Miner Res       Date:  1993-10       Impact factor: 6.741

9.  High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma.

Authors:  O F Ballester; L C Moscinski; G H Lyman; J V Chaney; H I Saba; A S Spiers; C Klein
Journal:  Blood       Date:  1994-04-01       Impact factor: 22.113

10.  Antitumor activity of recombinant interleukin 6 in mice.

Authors:  J J Mulé; J K McIntosh; D M Jablons; S A Rosenberg
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more
  15 in total

1.  [The elderly patient--who is that?].

Authors:  C C Sieber
Journal:  Internist (Berl)       Date:  2007-11       Impact factor: 0.743

Review 2.  Innate immunity and aging.

Authors:  Christian R Gomez; Vanessa Nomellini; Douglas E Faunce; Elizabeth J Kovacs
Journal:  Exp Gerontol       Date:  2008-06-11       Impact factor: 4.032

Review 3.  Determinants of health and disease.

Authors:  S Wolf
Journal:  Integr Physiol Behav Sci       Date:  1996 Jan-Mar

4.  [The concept of frailty--from phenomenology to therapeutic approaches].

Authors:  C C Sieber
Journal:  Z Gerontol Geriatr       Date:  2005-09       Impact factor: 1.281

Review 5.  Lipid-lowering drugs.

Authors:  K Pahan
Journal:  Cell Mol Life Sci       Date:  2006-05       Impact factor: 9.261

Review 6.  Physiological and pathological roles of interleukin-6 in the central nervous system.

Authors:  D L Gruol; T E Nelson
Journal:  Mol Neurobiol       Date:  1997-12       Impact factor: 5.590

Review 7.  Reactive astrocytes as therapeutic targets for CNS disorders.

Authors:  Mary E Hamby; Michael V Sofroniew
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 8.  Inflammatory markers in population studies of aging.

Authors:  Tushar Singh; Anne B Newman
Journal:  Ageing Res Rev       Date:  2010-12-08       Impact factor: 10.895

9.  Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates.

Authors:  Ilhem Messaoudi; Jessica Warner; Miranda Fischer; Buyng Park; Brenna Hill; Julie Mattison; Mark A Lane; George S Roth; Donald K Ingram; Louis J Picker; Daniel C Douek; Motomi Mori; Janko Nikolich-Zugich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-11       Impact factor: 11.205

10.  Survival and cell mediated immunity after burn injury in aged mice.

Authors:  Elizabeth J Kovacs; Kristy A Grabowski; Lisa A Duffner; Timothy P Plackett; Meredith S Gregory
Journal:  J Am Aging Assoc       Date:  2002-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.